BR100 Decreased By (-0.56%)
BR30 Decreased By (-0.63%)
KSE100 Decreased By (-0.49%)
KSE30 Decreased By (-0.74%)
AGHA 6.45 Decreased By ▼ -0.20 (-3.01%)
BECO 4.16 Decreased By ▼ -0.05 (-1.19%)
BML 57.31 Decreased By ▼ -1.91 (-3.23%)
BOP 28.15 Decreased By ▼ -0.38 (-1.33%)
CNERGY 12.41 Decreased By ▼ -0.47 (-3.65%)
CSIL 5.36 Decreased By ▼ -0.09 (-1.65%)
FCCL 51.66 Increased By ▲ 0.36 (0.7%)
FFL 13.90 Decreased By ▼ -0.16 (-1.14%)
FNEL 1.08 Decreased By ▼ -0.02 (-1.82%)
KEL 5.72 Decreased By ▼ -0.29 (-4.83%)
KOSM 5.33 Decreased By ▼ -0.11 (-2.02%)
LOTCHEM 24.25 Decreased By ▼ -0.70 (-2.81%)
MLCF 89.64 Increased By ▲ 0.41 (0.46%)
NBP 156.57 Decreased By ▼ -0.72 (-0.46%)
NCPL 47.02 Decreased By ▼ -1.12 (-2.33%)
NPL 51.96 Decreased By ▼ -0.69 (-1.31%)
OGDC 300.01 Increased By ▲ 0.54 (0.18%)
PACE 9.26 Decreased By ▼ -0.21 (-2.22%)
PAEL 33.01 Decreased By ▼ -0.61 (-1.81%)
PIBTL 13.19 Decreased By ▼ -0.29 (-2.15%)
PPL 214.32 Decreased By ▼ -4.53 (-2.07%)
PRL 101.44 Decreased By ▼ -7.37 (-6.77%)
PTC 52.24 Decreased By ▼ -1.52 (-2.83%)
SSGC 23.15 Increased By ▲ 0.38 (1.67%)
TBL 9.09 Decreased By ▼ -0.17 (-1.84%)
TELE 6.98 Decreased By ▼ -0.06 (-0.85%)
TPL 22.04 Increased By ▲ 2.00 (9.98%)
TPLP 11.69 Increased By ▲ 0.16 (1.39%)
TREET 22.80 Decreased By ▼ -0.55 (-2.36%)
TRG 57.13 Decreased By ▼ -0.49 (-0.85%)
By

WASHINGTON: US President Joe Biden’s steps to backstop hospitals and distribute coronavirus test kits, however welcome, are too little too late to stem a surge of Omicron-related coronavirus cases over Christmas and New Year’s, health experts said.

A day after Biden outlined plans to distribute 500 million at-home coronavirus test kits, Anne Rimoin, a UCLA professor of epidemiology, praised his focus on testing, a “critical tool” that the United States was “woefully” behind on.

“Unfortunately, it’s late in coming and will be a small drop in the bucket compared to the tsunami of cases on the horizon.”

The tests promised by the White House starting in January equate to just one or two per U.S. resident. Households need far more to make daily decisions about exposure, Rimoin said.

“We need those tests now,” she said. U.S. testing is behind the curve because of a lack of skilled workers, a shortage of at-home tests and under-investment in recent months, according to interviews with more than a dozen officials, health providers and testmakers.

Biden, a Democrat who took office in January, campaigned on a promise to take control of the pandemic, which his predecessor, Republican President Donald Trump, played down as hundreds of thousands died.

He has focused largely on persuading Americans to get vaccinated, amid pushback from many Republican leaders who reject vaccine and masking rules and an anti-vaccination movement fueled by conspiracy theories on social media. The United States recently passed 800,000 deaths the most in the world, and its vaccination rate lags most rich nations.

Biden’s latest measures, including new pop-up vaccination clinics run by the Federal Emergency Management Agency and federal testing sites in the hot spot of New York City and elsewhere, were welcomed by health experts and local politicians.

Comments

Comments are closed for this article.